DNA methylation changes following DNA damage in prostate cancer cells

Many cancer therapies operate by inducing double-strand breaks (DSBs) in cancer cells, however treatment-resistant cells rapidly initiate mechanisms to repair damage enabling survival. While the DNA repair mechanisms responsible for cancer cell survival following DNA damaging treatments are becoming...

Full description

Bibliographic Details
Main Authors: Laura P. Sutton, Sarah A. Jeffreys, Jessica L. Phillips, Phillippa C. Taberlay, Adele F. Holloway, Mark Ambrose, Ji-Hoon E. Joo, Arabella Young, Rachael Berry, Marketa Skala, Kate H. Brettingham-Moore
Format: Article
Language:English
Published: Taylor & Francis Group 2019-10-01
Series:Epigenetics
Subjects:
Online Access:http://dx.doi.org/10.1080/15592294.2019.1629231
_version_ 1797678907882733568
author Laura P. Sutton
Sarah A. Jeffreys
Jessica L. Phillips
Phillippa C. Taberlay
Adele F. Holloway
Mark Ambrose
Ji-Hoon E. Joo
Arabella Young
Rachael Berry
Marketa Skala
Kate H. Brettingham-Moore
author_facet Laura P. Sutton
Sarah A. Jeffreys
Jessica L. Phillips
Phillippa C. Taberlay
Adele F. Holloway
Mark Ambrose
Ji-Hoon E. Joo
Arabella Young
Rachael Berry
Marketa Skala
Kate H. Brettingham-Moore
author_sort Laura P. Sutton
collection DOAJ
description Many cancer therapies operate by inducing double-strand breaks (DSBs) in cancer cells, however treatment-resistant cells rapidly initiate mechanisms to repair damage enabling survival. While the DNA repair mechanisms responsible for cancer cell survival following DNA damaging treatments are becoming better understood, less is known about the role of the epigenome in this process. Using prostate cancer cell lines with differing sensitivities to radiation treatment, we analysed the DNA methylation profiles prior to and following a single dose of radiotherapy (RT) using the Illumina Infinium HumanMethylation450 BeadChip platform. DSB formation and repair, in the absence and presence of the DNA hypomethylating agent, 5-azacytidine (5-AzaC), were also investigated using γH2A.X immunofluorescence staining. Here we demonstrate that DNA methylation is generally stable following a single dose of RT; however, a small number of CpG sites are stably altered up to 14 d following exposure. While the radioresistant and radiosensitive cells displayed distinct basal DNA methylation profiles, their susceptibility to DNA damage appeared similar demonstrating that basal DNA methylation has a limited influence on DSB induction at the regions examined. Recovery from DSB induction was also similar between these cells. Treatment with 5-AzaC did not sensitize resistant cells to DNA damage, but rather delayed recruitment of phosphorylated BRCA1 (S1423) and repair of DSBs. These results highlight that stable epigenetic changes are possible following a single dose of RT and may have significant clinical implications for cancer treatment involving recurrent or fractionated dosing regimens.
first_indexed 2024-03-11T23:06:46Z
format Article
id doaj.art-ad75c7e39ad14f7f8858b1600d8512c4
institution Directory Open Access Journal
issn 1559-2294
1559-2308
language English
last_indexed 2024-03-11T23:06:46Z
publishDate 2019-10-01
publisher Taylor & Francis Group
record_format Article
series Epigenetics
spelling doaj.art-ad75c7e39ad14f7f8858b1600d8512c42023-09-21T13:09:22ZengTaylor & Francis GroupEpigenetics1559-22941559-23082019-10-011410989100210.1080/15592294.2019.16292311629231DNA methylation changes following DNA damage in prostate cancer cellsLaura P. Sutton0Sarah A. Jeffreys1Jessica L. Phillips2Phillippa C. Taberlay3Adele F. Holloway4Mark Ambrose5Ji-Hoon E. Joo6Arabella Young7Rachael Berry8Marketa Skala9Kate H. Brettingham-Moore10University of TasmaniaUniversity of TasmaniaUniversity of TasmaniaUniversity of TasmaniaUniversity of TasmaniaUniversity of TasmaniaThe University of MelbourneUniversity of TasmaniaUniversity of TasmaniaRoyal Hobart HospitalUniversity of TasmaniaMany cancer therapies operate by inducing double-strand breaks (DSBs) in cancer cells, however treatment-resistant cells rapidly initiate mechanisms to repair damage enabling survival. While the DNA repair mechanisms responsible for cancer cell survival following DNA damaging treatments are becoming better understood, less is known about the role of the epigenome in this process. Using prostate cancer cell lines with differing sensitivities to radiation treatment, we analysed the DNA methylation profiles prior to and following a single dose of radiotherapy (RT) using the Illumina Infinium HumanMethylation450 BeadChip platform. DSB formation and repair, in the absence and presence of the DNA hypomethylating agent, 5-azacytidine (5-AzaC), were also investigated using γH2A.X immunofluorescence staining. Here we demonstrate that DNA methylation is generally stable following a single dose of RT; however, a small number of CpG sites are stably altered up to 14 d following exposure. While the radioresistant and radiosensitive cells displayed distinct basal DNA methylation profiles, their susceptibility to DNA damage appeared similar demonstrating that basal DNA methylation has a limited influence on DSB induction at the regions examined. Recovery from DSB induction was also similar between these cells. Treatment with 5-AzaC did not sensitize resistant cells to DNA damage, but rather delayed recruitment of phosphorylated BRCA1 (S1423) and repair of DSBs. These results highlight that stable epigenetic changes are possible following a single dose of RT and may have significant clinical implications for cancer treatment involving recurrent or fractionated dosing regimens.http://dx.doi.org/10.1080/15592294.2019.1629231prostate cancerdna damagedna repairdna methylationepigeneticsradiotherapytreatment responseradiation resistance
spellingShingle Laura P. Sutton
Sarah A. Jeffreys
Jessica L. Phillips
Phillippa C. Taberlay
Adele F. Holloway
Mark Ambrose
Ji-Hoon E. Joo
Arabella Young
Rachael Berry
Marketa Skala
Kate H. Brettingham-Moore
DNA methylation changes following DNA damage in prostate cancer cells
Epigenetics
prostate cancer
dna damage
dna repair
dna methylation
epigenetics
radiotherapy
treatment response
radiation resistance
title DNA methylation changes following DNA damage in prostate cancer cells
title_full DNA methylation changes following DNA damage in prostate cancer cells
title_fullStr DNA methylation changes following DNA damage in prostate cancer cells
title_full_unstemmed DNA methylation changes following DNA damage in prostate cancer cells
title_short DNA methylation changes following DNA damage in prostate cancer cells
title_sort dna methylation changes following dna damage in prostate cancer cells
topic prostate cancer
dna damage
dna repair
dna methylation
epigenetics
radiotherapy
treatment response
radiation resistance
url http://dx.doi.org/10.1080/15592294.2019.1629231
work_keys_str_mv AT laurapsutton dnamethylationchangesfollowingdnadamageinprostatecancercells
AT sarahajeffreys dnamethylationchangesfollowingdnadamageinprostatecancercells
AT jessicalphillips dnamethylationchangesfollowingdnadamageinprostatecancercells
AT phillippactaberlay dnamethylationchangesfollowingdnadamageinprostatecancercells
AT adelefholloway dnamethylationchangesfollowingdnadamageinprostatecancercells
AT markambrose dnamethylationchangesfollowingdnadamageinprostatecancercells
AT jihoonejoo dnamethylationchangesfollowingdnadamageinprostatecancercells
AT arabellayoung dnamethylationchangesfollowingdnadamageinprostatecancercells
AT rachaelberry dnamethylationchangesfollowingdnadamageinprostatecancercells
AT marketaskala dnamethylationchangesfollowingdnadamageinprostatecancercells
AT katehbrettinghammoore dnamethylationchangesfollowingdnadamageinprostatecancercells